The mechanism of TG in cancer is that high levels of serum TG can upregulate cell signal pathways (such as MEK/ERK and AKT pathways), which promote the development of oxidative stress, and reactive oxygen species, thereby leading to the proliferation and progression of cancer cells [12, 28, 29]. Here, MAP2K7 is linked to cancer.